Cargando…

Correction to: The year in cardiovascular medicine 2022: the top 10 papers in heart failure and cardiomyopathies

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10327875/ https://www.ncbi.nlm.nih.gov/pubmed/37225972 http://dx.doi.org/10.1093/eurheartj/ehad307

Ejemplares similares

The year in cardiovascular medicine 2022: the top 10 papers in heart failure and cardiomyopathies
por: de Boer, Rudolf A, et al.
Publicado: (2023)

The year in cardiovascular medicine 2022: the top 10 papers in cardiovascular imaging
por: Bucciarelli-Ducci, Chiara, et al.
Publicado: (2023)

The year in cardiovascular medicine 2022: the top 10 papers in cardio-oncology
por: Herrmann, Joerg, et al.
Publicado: (2023)

Erratum to: The year in cardiovascular medicine 2022: the top 10 papers in cardio-oncology
Publicado: (2023)

Correction to ‘10 years of research on toughness enhancement of structural ceramics by graphene’ (2022) by Cristina Ramírez
por: Ramírez, Cristina
Publicado: (2022)

Correction Lancet Respir Med 2022; 10: 937–48
Publicado: (2023)

Correction to Lancet Respir Med 2022; 10: 327–36
Publicado: (2022)

Correction to Lancet Respir Med 2022; 10: 679–88
Publicado: (2022)

Correction to Lancet Respir Med 2022; 10: 545–56
Publicado: (2022)

Correction to Lancet Respir Med 2022; 10: 630–31
Publicado: (2022)

Correction to Lancet Respir Med 2022; 10: 761–75
Publicado: (2022)

Correction to Lancet Respir Med 2022; 10: 700–14
Publicado: (2022)

Correction to Lancet Respir Med 2022; 10: 972–84
Publicado: (2022)

Correction: Relationships between sympathetic markers and heart rate thresholds for cardiovascular risk in chronic heart failure
por: Grassi, Guido, et al.
Publicado: (2022)

Correction to Lancet Glob Health 2022; 10: e715–72
Publicado: (2023)

Correction to Lancet Glob Health 2022; 10: e1632–45
Publicado: (2023)

Correction to Lancet Respir Med 2022; 10: e36–37
Publicado: (2022)

Correction to Lancet Glob Health 2022; 10: e482–90
Publicado: (2022)

Correction to Lancet Glob Health 2022; 10: e807–19
Publicado: (2022)

Correction to Lancet Glob Health 2022; 10: e1289–97
Publicado: (2022)

Author Correction: The phospholamban p.(Arg14del) pathogenic variant leads to cardiomyopathy with heart failure and is unresponsive to standard heart failure therapy
por: Eijgenraam, Tim R., et al.
Publicado: (2020)

Correction to: Updated Recommendations on Cardiovascular Prevention in 2022: An Executive Document of the Italian Society of Cardiovascular Prevention
por: Volpe, Massimo, et al.
Publicado: (2022)

Correction to: Exosomes in Cardiovascular Medicine
por: Dykes, Iain M.
Publicado: (2018)

Correction: Impact of cardiovascular magnetic resonance on management and clinical decision-making in heart failure patients
por: Abbasi, Siddique A, et al.
Publicado: (2014)

Correction: Farshadmand et al. Utility of Cardiac Power Hemodynamic Measurements in the Evaluation and Risk Stratification of Cardiovascular Conditions. Healthcare 2022, 10, 2417
por: Farshadmand, Jonathan, et al.
Publicado: (2023)

Correction: Top 50 most-cited articles in medicine and science in football
Publicado: (2018)

Correction to: Cardiovascular magnetic resonance native T(2) and T(2)(*) quantitative values for cardiomyopathies and heart transplantations: a systematic review and meta-analysis
por: Snel, G. J. H., et al.
Publicado: (2020)

Correction: reproducibility of in-vivo diffusion tensor cardiovascular magnetic resonance in hypertrophic cardiomyopathy
por: McGill, Laura-Ann, et al.
Publicado: (2013)

Correction: Lenarczyk et al. T Cells Contribute to Pathological Responses in the Non-Targeted Rat Heart following Irradiation of the Kidneys. Toxics 2022, 10, 797
por: Lenarczyk, Marek, et al.
Publicado: (2023)

Author Correction: Heart Failure Phenotypes Induced by Knockdown of DAPIT in Zebrafish: A New Insight into Mechanism of Dilated Cardiomyopathy
por: Nagata, Yoji, et al.
Publicado: (2018)

Correction to Lancet Microbe 2022; published online Dec 19, 2022. https://doi.org/10.1016/S2666-5247(22)00301-9
Publicado: (2023)

Correction: Efficacy of antihyperglycemic therapies on cardiovascular and heart failure outcomes: an updated meta-analysis and meta-regression analysis of 35 randomized cardiovascular outcome trials
por: Hasebe, Masashi, et al.
Publicado: (2023)

Correction: Right atrial volume by cardiovascular magnetic resonance predicts mortality in patients with heart failure with reduced ejection fraction
Publicado: (2017)

Correction: Plasma kynurenines and prognosis in patients with heart failure
por: Lund, Anders, et al.
Publicado: (2020)

China’s top 10 achievements in hematology in 2022
por: Wang, Xiaochen
Publicado: (2023)

Correction to Lancet Microbe 2022; published online Jan 10. https://doi.org/10.1016/S2666-5247(21)00245-7
Publicado: (2022)

Correction: PARS risk charts: A 10-year study of risk assessment for cardiovascular diseases in Eastern Mediterranean Region
por: Sarrafzadegan, Nizal, et al.
Publicado: (2018)

Correction to: Mituru Takanami, 1929–2022
Publicado: (2023)

Correction to: “Heart failure: an update from the last years and a look at the near future” and articles listed below
Publicado: (2023)

Correction: Latov, N. Campylobacter jejuni Infection, Anti-Ganglioside Antibodies, and Neuropathy. Microorganisms 2022, 10, 2139
por: Latov, Norman
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_sqpj8kmfjjlbv8v4drnnove3g4